cebpd antibody (Abmart Inc)
Structured Review

Cebpd Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cebpd+antibody/pmc12571002-81-9-14?v=Abmart+Inc
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis"
Article Title: Identification and Validation of Lipid Metabolism-Related Biomarkers GPD1 and CEBPD in Metabolic Dysfunction-Associated Steatohepatitis
Journal: Journal of Inflammation Research
doi: 10.2147/JIR.S524204
Figure Legend Snippet: Diagnostic Performance and Clinical Relevance of CEBPD and GPD1 in MASH Patients. ( A ) Comparison of risk distributions between patients with MASH and healthy controls in the test set. ( B ) ROC curves assessed the model’s diagnostic performance in the test set. ROC curves assessed the diagnostic performance of CEBPD ( C ) and GPD1 ( D ) in the train set. ( E ) Comparison of CEBPD and GPD1 expression levels between patients with MASH and HC in the test set. ROC curves evaluated the diagnostic performance of CEBPD ( F ) and GPD1 ( G ) in the test set. ( H and I ) The association between the expression level of CEBPD and GPD1 and the fibrosis stage. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Techniques Used: Diagnostic Assay, Comparison, Expressing
Figure Legend Snippet: Immune Cell Profiling and Correlation with CEBPD and GPD1 Expression in MASH. ( A ) Heatmap showing correlations between 28 immune cell types in MerCorhort. ( B ) Heatmap showing the infiltrating enrichment of 28 immune cell types in MerCorhort. ( C ) Boxplot depicting differences in immune cell infiltration between patients with MASH and healthy controls. ( D ) Heatmap showing the correlation between CEBPD and GPD1 expression and immune cells in MASH. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns not significant ( p ≥ 0.05).
Techniques Used: Expressing
Figure Legend Snippet: Validation of GPD1 and CEBPD in a MASH Animal Model. ( A ) IHC staining of normal and MASH liver tissues, n = 6, 400×, scale bar 100 μm. ( B ) AOD values for GPD1 in CON and MASH groups. ( C ) AOD values for CEBPD in CON and MASH groups. ( D ) WB analysis of normal and MASH liver tissues, n = 3. ( E ) Relative gray value measurements for GPD1 in CON and MASH groups. ( F ) Relative gray value measurements for CEBPD in CON and MASH groups. *** p ≤ 0.001.**** p ≤ 0.0001.
Techniques Used: Biomarker Discovery, Animal Model, Immunohistochemistry
